主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACXP
#4342
Acurx Pharmaceuticals, Inc. Common Stock
3.880
0
USD
-22.55%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-22.55%
每月变动
+102.08%
6个月变化
+102.08%
年变化
+102.08%
前一天收盘价
5.010
0
Open
3.880
0
Bid
3.880
0
Ask
3.883
0
Low
3.880
0
High
3.880
0
交易量
12
市场
股票
医疗保健
ACXP
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
511.66 K
581.79 K
787.86 K
1.1 M
2.86 M
—
Valuation ratios
Enterprise value
—
—
—
—
-447.09 K
—
Price to earnings ratio
—
—
—
—
-0.47
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
-0.55
—
Price to book ratio
—
—
—
—
0.71
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.96
-1.29
-1.89
-3.66
-1.04
-1.34
Return on equity %
-1.03
-1.65
-3.12
-22.93
-1.51
-2.41
Return on invested capital %
124.55 K
329.02 K
-101.32 K
-70 K
-111.92 K
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.75
4.54
2.5
1.17
3.18
9.95
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-11.75
-13.95
-15.47
-12.85
-4.53
-5.4
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
30.46
16.83
11.84
4.58
5.04
18.39
Net current asset value per share
31.15
17.32
12
4.7
5.13
18.85
Tangible book value per share
29.08
13.53
7.37
0.76
3.52
11.06
Working capital per share
29.17
13.5
7.2
0.69
3.52
11.05
Book value per share
29.08
13.53
7.37
0.76
3.52
11.06
新闻
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript
Acurx Pharmaceuticals 2025财年第四季度财报:现金储备增加,研发进展显著
Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress
Acurx Pharmaceuticals股价上涨超3%,新rCDI试验启动
Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch
What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)
Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)
美国股市涨跌不一;截至收盘道琼斯工业平均指数下跌0.61%
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?
Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript